Are exosomes, stem cells and cell-derived products the same thing?

Exosomes are not cells; they describe a non-replicating subtype of extracellular vesicle released by cells. Stem-cell-derived, conditioned medium, secretome, cell lysate and purified extracellular vesicles do not describe the same product. Composition and regulatory status cannot be inferred from a marketing label.

This translation has no recorded clinical or medical-language review.

Direct answer

Naming the source cell does not show that the final product contains living stem cells.
Calling a preparation exosomes requires evidence about biogenesis and characterization.
Cell-free does not mean sterile, pure, consistently dosed or clinically validated.

What scientific terms separate

MISEV2023 favours operational terms such as small extracellular vesicles when cellular origin has not been demonstrated. Exosome refers to vesicles formed through an endosomal pathway inside cells. Particle size or a few surface markers alone cannot show that every particle in a preparation is an exosome; proteins, lipoproteins and other extracellular particles may coexist.

What might be inside the label?

A vial may contain purified vesicles, conditioned culture medium, plant-derived particles, synthetic liposomes or mixtures with carriers. If donor and cell source, manufacture, separation, characterization, sterility, endotoxin, storage and batch acceptance are not documented, a stem-cell technology phrase does not supply the missing information.

Verify the clinical claim separately

Laboratory identity and clinical safety or effectiveness are different questions. Look for human evidence involving the exact source, product, route, dose, comparator and follow-up. FDA's statement that no exosome product is approved in the United States does not determine status in every country; classification and permission in Türkiye require separate official verification.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Microneedling for Facial Rejuvenation: A Systematic Review
Foppiani JA et al. · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Evaluating the Effectiveness and Safety of Radiofrequency for Face and Neck Rejuvenation: A Systematic Review
Austin GK, Struble SL, Quatela VC · 2022
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Energy-Based Devices for the Treatment of Facial Skin Conditions in Skin of Color
Sanyal RD, Fabi SG · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication
U.S. Food and Drug Administration (FDA) · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
A Systematic Review and Meta-Analysis of Efficacy, Safety, and Satisfaction Rates of Laser Combination Treatments vs Laser Monotherapy in Skin Rejuvenation Resurfacing
Pour Mohammad A et al. · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Outcomes and Adverse Effects of Ablative vs Nonablative Lasers for Skin Resurfacing: A Systematic Review of 1093 Patients
Mirza HN, Mirza FN, Khatri KA · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Medical Lasers
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Minimal Information for Studies of Extracellular Vesicles (MISEV2023)
International Society for Extracellular Vesicles consensus authors · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Public Safety Notification on Exosome Products
U.S. Food and Drug Administration (FDA) · 2019
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
J. C. Flores Rodríguez et al. · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review